XNCR
$46.76
Xencor
($1.74)
(3.59%)
XNCR
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  ($0.69)
Revenue:  N/A
Tuesday
May 25
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when XNCR reports earnings?
Beat
Meet
Miss

Where is XNCR's stock price going from here?
Up
Flat
Down
Stock chart of XNCR
Analysts
Summary of analysts' recommendations for XNCR
Score
Grade
Pivots
Resistance
$66.12
$62.23
$55.37

$51.48

Support
$44.61
$40.72
$33.86
Tweet
Growth
Description
Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.
Peers
InterCeptVertex PharmaceuticalsRegeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbPfizerZoetisMerck & Co.Johnson & JohnsonUltragenyx Pharmaceutical